Literature DB >> 7202884

Increased killer cell activity in insulin dependent (type 1) diabetes mellitus.

M Sensi, P Pozzilli, A N Gorsuch, G F Bottazzo, A G Cudworth.   

Abstract

Antibody dependent cell mediated cytotoxicity in relation to the levels of circulating killer cells was investigated in 16 newly diagnosed classical insulin dependent (Type 1) diabetics, 11 islet cell antibody positive non diabetic children with at least one HLA haplotype in common with their diabetic sibling, and in 15 normal controls. Antibody dependent cell mediated cytotoxicity was evaluated using, as target, 51Cr labelled human 0+ erythrocytes sensitised with an anti-CD antiserum. Killer cells were measured by the low affinity E-rosetting cell technique. Increased killer cell levels (greater than normal mean + 2SD) were accompanied by a significant enhancement in antibody dependent cell mediated cytotoxicity both in newly diagnosed diabetics (p less than 0.05) and in unaffected siblings (p less than 0.01). These preliminary results indicate that raised antibody dependent cell mediated cytotoxicity is a feature of insulin dependent diabetes at diagnosis and suggest that active B cell damage might be occurring some time before the onset of clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7202884     DOI: 10.1007/bf00262010

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

Review 1.  HLA-A, -B and -C antigens, their serology and cross-reaction.

Authors:  V C Joysey; E Wolf
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

2.  An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus.

Authors:  K Junker; J Egeberg; H Kromann; J Nerup
Journal:  Acta Pathol Microbiol Scand A       Date:  1977-09

3.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

4.  Low affinity E-rosette formation by the human K cell.

Authors:  W H West; R B Boozer; R B Herberman
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

5.  Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.

Authors:  W J Irvine; S F Al-Khateeb; U Di Mario; C M Feek; R S Gray; B Edmond; L J Duncan
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

6.  Human lymphocyte antibody-dependent cell-mediated cytotoxicity (ADCC) toward human red blood cells.

Authors:  G M Shaw; P C Levy; A F LoBuglio
Journal:  Blood       Date:  1978-10       Impact factor: 22.113

7.  T, B and K cells in autoimmune thyroid disease.

Authors:  E A Calder; W J Irvine; N M Davidson; F Wu
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

8.  Insulin-dependent diabetes: a disease of autoaggression.

Authors:  S W Huang; N K Maclaren
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

9.  Complement-mediated cytotoxic effects on pancreatic islets with sera from diabetic patients.

Authors:  H G Rittenhouse; D L Oxender; S Pek; D Ar
Journal:  Diabetes       Date:  1980-04       Impact factor: 9.461

10.  Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage.

Authors:  G F Bottazzo; B M Dean; A N Gorsuch; A G Cudworth; D Doniach
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

View more
  21 in total

1.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

Review 2.  Disordered cellular immunity in type I diabetes of man and the BB rat.

Authors:  J B Buse; R F Rowley; G S Eisenbarth
Journal:  Surv Immunol Res       Date:  1982

Review 3.  Altered immunity and diabetes in the BB rat.

Authors:  J F Yale; E B Marliss
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

Review 4.  Immunology in the early stages of type I diabetes.

Authors:  U Di Mario; P Pozzilli; D Andreani
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

5.  Immune islet killing mechanisms associated with insulin-dependent diabetes: three rabbit antibody-mediated islet cell cytotoxicity models.

Authors:  M A Charles; M Suzuki; L Slater; N Waldeck; K Ong
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

6.  Auto-immunity in children with diabetes mellitus and in their relatives.

Authors:  R Lorini; D Larizza; C Livieri; V Cammareri; A Martini; A Plebani; D Zanaboni; F Severi
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

7.  Islet cell surface antibodies from insulin-dependent diabetics bind specifically to pancreatic B cells.

Authors:  M Van De Winkel; G Smets; W Gepts; D Pipeleers
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

Review 8.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

9.  An investigation into cytotoxic mechanisms in type I diabetes mellitus.

Authors:  E R Richens; J Quilley; M Hartog
Journal:  Acta Diabetol Lat       Date:  1982 Oct-Dec

10.  Antibody-dependent and natural killer cytotoxicity in type 1 diabetes.

Authors:  M Sensi; P Pozzilli; A G Cudworth
Journal:  Acta Diabetol Lat       Date:  1981 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.